The effects of flap ischemia on normal and diabetic progenitor cell function

Plastic and Reconstructive Surgery

Volumn 121, Issue 6, 2008, Pages 1929-1942

  Tanaka, Rica ^a   Wada, Mika ^a   Kwon, Sang Mo ^a   Masuda, Haruchika ^a   Carr, Jacquelyn ^a   Ito, Rie ^a   Miyasaka, Muneo ^a   Warren, Stephen M ^a   Asahara, Takayuki ^a   Tepper, Oren M ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL ASSAY; CELL COUNT; CELL CULTURE; CELL DIFFERENTIATION; CELL FUNCTION; CELL ISOLATION; COLONY FORMING UNIT; CONTROLLED STUDY; DIABETES MELLITUS; ENDOTHELIUM CELL; FLAP ISCHEMIA; FLUORESCENCE ACTIVATED CELL SORTING; GRAFT DYSFUNCTION; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; STEM CELL; STEM CELL MOBILIZATION; WILD TYPE; ANIMAL; BONE MARROW CELL; C57BL MOUSE; CELL MOTION; CLONOGENIC ASSAY; CYTOLOGY; DISEASE MODEL; EXPERIMENTAL DIABETES MELLITUS; ISCHEMIA; NONPARAMETRIC TEST; PHYSIOLOGY; PLASTIC SURGERY; PROBABILITY; RANDOMIZATION; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; VASCULARIZATION;

ANIMALS; BONE MARROW CELLS; CELL COUNT; CELL MOVEMENT; CELLS, CULTURED; COLONY-FORMING UNITS ASSAY; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; ISCHEMIA; MALE; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PHYSIOLOGIC; PROBABILITY; RANDOM ALLOCATION; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC; STEM CELLS; SURGICAL FLAPS;

EID: 48049089641     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0b013e3181715218     Document Type: Article

References (52)

1. Tepper, O. M., Galiano, R. D., Kalka, C., et al. Endothelial progenitor cells: The promise of vascular stem cells for plastic surgery. Plast. Reconstr. Surg. 111: 846, 2003.
2. Zuk, P. A., Zhu, M., Ashjian, P., et al. Human adipose tissue is a source of multipotent stem cells. Mol. Biol. Cell. 13: 4279, 2002.
3. Joannides, A., Gaughwin, P., Schwiening, C., et al. Efficient generation of neural precursors from adult human skin: Astrocytes promote neurogenesis from skin-derived stem cells. Lancet 364: 172, 2004.
4. Becker, C., and Jakse, G. Stem cells for regeneration of urological structures. Eur. Urol. 51: 1217, 2007.
5. Srivastava, D., and Ivey, K. N. Potential of stem-cell-based therapies for heart disease. Nature 441: 1097, 2006.
6. Sharma, A. D., Cantz, T., Manns, M. P., et al. The role of stem cells in physiology, pathophysiology, and therapy of the liver. Stem Cell Rev. 2: 51, 2006.
7. Boyce, S. T., Anderson, B. A., and Rodriguez-Rilo, H. L. Quantitative assay for quality assurance of human cells for clinical transplantation. Cell Transplant. 15: 169, 2006.
8. Lima, C., Pratas-Vital, J., Escada, P., et al. Olfactory mucosa autografts in human spinal cord injury: A pilot clinical study. J. Spinal Cord Med. 29: 191, 2006.
9. Burget, G.C., and Menick, F. J. Nasal support and lining: The marriage of beauty and blood supply. Plast. Reconstr. Surg. 84: 189, 1989.
10. Asahara, T., Masuda, H., Takahashi, T., et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ. Res. 85: 221, 1999.
11. Takahashi, T., Kalka, C., Masuda, H., et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat. Med. 5: 434, 1999.
12. Asahara, T., Murohara, T., Sullivan, A., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275: 964, 1997.
13. Asahara, T., Takahashi, T., Masuda, H., et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J. 18: 3964, 1999.
14. Murohara, T., Ikeda, H., Duan, J., et al. Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J. Clin. Invest. 105: 1527, 2000.
15. Kalka, C., Masuda, H., Takahashi, T., et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc. Natl. Acad. Sci. U.S.A. 97: 3422, 2000.
16. Folkman, J., and Shing, Y. Control of angiogenesis by heparin and other sulfated polysaccharides. Adv. Exp. Med. Biol. 313: 355, 1992.
17. Risau, W., Sariola, H., Zerwes, H. G., et al. Vasculogenesis and angiogenesis in embryonic-stem-cell-derived embryoid bodies. Development 102: 471, 1988.
18. Murayama, T., Tepper, O. M., Silver, M., et al. Determination of bone marrow-derived endothelial progenitor cell significance in angiogenic growth factor-induced neovascularization in vivo. Exp. Hematol. 30: 967, 2002.
19. Capla, J. M., Grogan, R. H., Callaghan, M. J., et al. Diabetes impairs endothelial progenitor cell-mediated blood vessel formation in response to hypoxia. Plast. Reconstr. Surg. 119: 59, 2007.
20. Ceradini, D. J., Kulkarni, A. R., Callaghan, M. J., et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat. Med. 10: 858, 2004.
21. Park, S., Tepper, O. M., Galiano, R. D., et al. Selective recruitment of endothelial progenitor cells to ischemic tissues with increased neovascularization. Plast. Reconstr. Surg. 113: 284, 2004.
22. Tepper, O. M., Capla, J. M., Galiano, R. D., et al. Adult vasculogenesis occurs through in situ recruitment, proliferation, and tubulization of circulating bone marrow-derived cells. Blood 105: 1068, 2005.
23. Tepper, O. M., Galiano, R. D., Capla, J. M., et al. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 106: 2781, 2002.
24. Loomans, C.J., de Koning, E. J., Staal, F. J., et al. Endothelial progenitor cell dysfunction: A novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes 53: 195, 2004.
25. Westermann, D., Rutschow, S., Van Linthout, S., et al. Inhibition of p38 mitogen-activated protein kinase attenuates left ventricular dysfunction by mediating pro-inflammatory cardiac cytokine levels in a mouse model of diabetes mellitus. Diabetologia 49: 2507, 2006.
26. Ishikawa, T., Eguchi, M., Wada, M., et al. Establishment of a functionally active collagen-binding vascular endothelial growth factor fusion protein in situ. Arterioscler. Thromb. Vasc. Biol. 26: 1998, 2006.
27. Llevadot, J., Murasawa, S., Kureishi, Y., et al. HMG-CoA reductase inhibitor mobilizes bone marrow-derived endothelial progenitor cells. J. Clin. Invest. 108: 399, 2001.
28. Masuda, H., Kalka, C, Takahashi, T., et al. Estrogen-mediated endothelial progenitor cell biology and kinetics for physiological postnatal vasculogenesis. Circ. Res. 101: 598, 2007.
29. Rustemeyer, P., Wittkowski, W., Greve, B., et al. Flow-cytometric identification, enumeration, purification, and expansion of CD133+ and VEGF-R2+ endothelial progenitor cells from peripheral blood. J. Immunoassay Immunochem. 28: 13, 2007.
30. Benndorf, R. A., Gehling, U. M., Appel, D., etal. Mobilization of putative high-proliferative-potential endothelial colony-forming cells during antihypertensive treatment in patients with essential hypertension. Stem Cells Dev. 16: 329, 2007.
31. Tsukada, S., Masuda, H., Kwon, S., et al. Establishment of vasculogenic colony forming assay in murine endothelial progenitor cells. Circ. J. 71: 269, 2007.
32. Masuda, H., Tanaka, R., Yoshida, M., et al. Establishment of a novel hierarchical clonogenic assay identifies unique population of endothelial progenitor cells (Abstract). Plast. Reconstr. Surg. 2007.
33. Yamaguchi, J., Kusano, K. F., Masuo, O., et al. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 107: 1322, 2003.
34. Massa, M., Rosti, V., Ferrario, M., et al. Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction. Blood 105: 199, 2005.
35. Qin, G, Ii, M., Silver, M., et al. Functional disruption of alpha4 integrin mobilizes bone marrow-derived endothelial progenitors and augments ischemic neovascularization. J. Exp. Med. 203: 153, 2006.
36. Kawamoto, A., Asahara, T., and Losordo, D. W. Transplantation of endothelial progenitor cells for therapeutic neovascularization. Cardiovasc. Radiat. Med. 3: 221, 2002.
37. Bailey, A. S., Jiang, S., Afentoulis, M., et al. Transplanted adult hematopoietic stems cells differentiate into functional endothelial cells. Blood 103: 13, 2004.
38. Nishikawa, S. I., Hirashima, M., Nishikawa, S., et al. Cell biology of vascular endothelial cells. Ann. N. Y. Acad. Sci. 947: 35, 2001.
39. Nishikawa, S. I. A complex linkage in the developmental pathway of endothelial and hematopoietic cells. Curr. Opin. Cell Biol. 13: 673, 2001.
40. Heissig, B., Rafii, S., Akiyama, H., et al. Low-dose irradiation promotes tissue revascularization through VEGF release from mast cells and MMP-9-mediated progenitor cell mobilization. J. Exp. Med. 202: 739, 2005.
41. Brownlee, M. The pathobiology of diabetic complications: A unifying mechanism. Diabetes 54: 1615, 2005.
42. Seeger, F. H., Haendeler, J., Walter, D. H., et al. p38 mitogen-activated protein kinase downregulates endothelial progenitor cells. Circulation 111: 1184, 2005.
43. Krankel, N., Adams, V., Linke, A., et al. Hyperglycemia reduces survival and impairs function of circulating blood-derived progenitor cells. Arterioscler. Thromb. Vasc. Biol. 25:698, 2005.
44. Callaghan, M. J., Ceradini, D. J., and Gurtner, G. C. Hyper-glycemia-induced reactive oxygen species and impaired endothelial progenitor cell function. Antioxid. Redox Signal. 7: 1476, 2005.
45. Humpert, P. M., Neuwirth, R., Battista, M. J., et al. SDF-1 genotype influences insulin-dependent mobilization of adult progenitor cells in type 2 diabetes. Diabetes Care 28: 934, 2005.
46. Gadau, S., Emanueli, C., Van Linthout, S., et al. Benfotiamine accelerates the healing of ischaemic diabetic limbs in mice through protein kinase B/Akt-mediated potentiation of angiogenesis and inhibition of apoptosis. Diabetologia 49: 405, 2006.
47. Ingram, D. A., Krier, T. R., Mead, L. E., et al. Clonogenic endothelial progenitor cells are sensitive to oxidative stress. Stem Cells 25: 297, 2007.
48. Kawamoto, A., Gwon, H. C., Iwaguro, H., et al. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 103: 634, 2001.
49. Kubota, Y., Kishi, K., Satoh, H., et al. Transplanted endothelial progenitor cells augment the survival areas of rat dorsal flaps. Cell Transplant 12: 647, 2003.
50. Schatteman, G. C., and Ma, N. Old bone marrow cells inhibit skin wound vascularization. Stem Cells 24: 717, 2006.
51. Awad, O., Jiao, C., Ma, N., et al. Obese diabetic mouse environment differentially affects primitive and monocytic endothelial cell progenitors. Stem Cells 23: 575, 2005.
52. Hill, J. M., Zalos, G., Halcox, J. P., et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N. Engl. J. Med. 348: 593, 2003.